Autolus Therapeutics (NASDAQ:AUTL) initiated with Buy rating and $26 (99% upside) price target at Needham.
Edwards Lifesciences (NYSE:EW) initiated with Overweight rating and $240 (9% upside) price target at Piper Jaffray.
Elanco Animal Health (NYSE:ELAN) initiated with Overweight rating and $36 (31% upside) price target at Barclays.
Sanofi (NASDAQ:SNY) upgraded to Buy at with a €96 (14% upside)at Guggenheim. Shares down 1% premarket.
Akcea Therapeutics (NASDAQ:AKCA) downgraded to Market Perform with a $24 (7% upside) price target at Wells Fargo.
Avita Medical (OTCQX:AVMXY) downgraded to Speculative Hold at Bell Potter.
Sabra Health Care REIT (NASDAQ:SBRA) downgraded to Sell at Citigroup.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.